{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:08:18Z","timestamp":1756462098680},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T00:00:00Z","timestamp":1546992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T00:00:00Z","timestamp":1546992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiol Ther"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s40119-018-0124-z","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T13:18:52Z","timestamp":1547039932000},"page":"145-150","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Treatment of Orthostatic Hypotension Due to Autonomic Dysfunction (Neurogenic Orthostatic Hypotension) in a Patient with Cardiovascular Disease and Parkinson's Disease"],"prefix":"10.1007","volume":"8","author":[{"given":"Peter A.","family":"McCullough","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,9]]},"reference":[{"issue":"2","key":"124_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10286-011-0119-5","volume":"21","author":"R Freeman","year":"2011","unstructured":"Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21(2):69\u201372.","journal-title":"Clin Auton Res"},{"issue":"9","key":"124_CR2","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1007\/s00415-012-6736-7","volume":"260","author":"M Metzler","year":"2013","unstructured":"Metzler M, Duerr S, Granata R, Krismer F, Robertson D, Wenning GK. Neurogenic orthostatic hypotension: pathophysiology, evaluation, and management. J Neurol. 2013;260(9):2212\u20139.","journal-title":"J Neurol"},{"issue":"8","key":"124_CR3","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s00415-016-8375-x","volume":"264","author":"CH Gibbons","year":"2017","unstructured":"Gibbons CH, Schmidt P, Biaggioni I, et al. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol. 2017;264(8):1567\u201382.","journal-title":"J Neurol"},{"issue":"2","key":"124_CR4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10286-011-0146-2","volume":"22","author":"H Kaufmann","year":"2012","unstructured":"Kaufmann H, Malamut R, Norcliffe-Kaufmann L, Rosa K, Freeman R. The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale. Clin Auton Res. 2012;22(2):79\u201390.","journal-title":"Clin Auton Res"},{"issue":"2","key":"124_CR5","first-page":"101","volume":"27","author":"S Maule","year":"2012","unstructured":"Maule S, Milazzo V, Maule MM, Di Stefano C, Milan A, Veglio F. Mortality and prognosis in patients with neurogenic orthostatic hypotension. Funct Neurol. 2012;27(2):101\u20136.","journal-title":"Funct Neurol"},{"issue":"9","key":"124_CR6","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/S1474-4422(16)30079-5","volume":"15","author":"AJ Espay","year":"2016","unstructured":"Espay AJ, LeWitt PA, Hauser RA, Merola A, Masellis M, Lang AE. Neurogenic orthostatic hypotension and supine hypertension in Parkinson\u2019s disease and related synucleinopathies: prioritisation of treatment targets. Lancet Neurol. 2016;15(9):954\u201366.","journal-title":"Lancet Neurol"},{"issue":"2","key":"124_CR7","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1161\/HYPERTENSIONAHA.115.06617","volume":"67","author":"AC Arnold","year":"2016","unstructured":"Arnold AC, Okamoto LE, Gamboa A, et al. Mineralocorticoid receptor activation contributes to the supine hypertension of autonomic failure. Hypertension. 2016;67(2):424\u20139.","journal-title":"Hypertension"},{"issue":"8","key":"124_CR8","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s40263-017-0453-9","volume":"31","author":"J Baker","year":"2017","unstructured":"Baker J, Kimpinski K. Management of supine hypertension complicating neurogenic orthostatic hypotension. CNS Drugs. 2017;31(8):653\u201363.","journal-title":"CNS Drugs"},{"issue":"6","key":"124_CR9","doi-asserted-by":"publisher","first-page":"e0128962","DOI":"10.1371\/journal.pone.0128962","volume":"10","author":"D Nilsson","year":"2015","unstructured":"Nilsson D, Sutton R, Tas W, Burri P, Melander O, Fedorowski A. Orthostatic changes in hemodynamics and cardiovascular biomarkers in dysautonomic patients. PLoS One. 2015;10(6):e0128962.","journal-title":"PLoS One"},{"issue":"5","key":"124_CR10","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1161\/01.HYP.30.5.1062","volume":"30","author":"J Shannon","year":"1997","unstructured":"Shannon J, Jordan J, Costa F, Robertson RM, Biaggioni I. The hypertension of autonomic failure and its treatment. Hypertension. 1997;30(5):1062\u20137.","journal-title":"Hypertension"},{"issue":"1","key":"124_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10286-015-0324-8","volume":"26","author":"T Umehara","year":"2016","unstructured":"Umehara T, Matsuno H, Toyoda C, Oka H. Clinical characteristics of supine hypertension in de novo Parkinson disease. Clin Auton Res. 2016;26(1):15\u201321.","journal-title":"Clin Auton Res"},{"key":"124_CR12","volume-title":"NORTHERA\u00ae (droxidopa). Full Prescribing Information","author":"Lundbeck NA Ltd","year":"2017","unstructured":"NORTHERA\u00ae (droxidopa). Full Prescribing Information. Deerfield: Lundbeck NA Ltd; 2017."},{"issue":"5","key":"124_CR13","doi-asserted-by":"publisher","first-page":"423","DOI":"10.5114\/ninp.2013.38222","volume":"47","author":"M Rudzinska","year":"2013","unstructured":"Rudzinska M, Bukowczan S, Stozek J, et al. Causes and consequences of falls in Parkinson disease patients in a prospective study. Neurol Neurochir Pol. 2013;47(5):423\u201330.","journal-title":"Neurol Neurochir Pol"},{"issue":"5","key":"124_CR14","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1136\/ip.2005.011015","volume":"12","author":"JA Stevens","year":"2006","unstructured":"Stevens JA, Corso PS, Finkelstein EA, Miller TR. The costs of fatal and non-fatal falls among older adults. Inj Prev. 2006;12(5):290\u20135.","journal-title":"Inj Prev"},{"issue":"18","key":"124_CR15","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1056\/NEJM199710303371806","volume":"337","author":"ME Tinetti","year":"1997","unstructured":"Tinetti ME, Williams CS. Falls, injuries due to falls, and the risk of admission to a nursing home. N Engl J Med. 1997;337(18):1279\u201384.","journal-title":"N Engl J Med"},{"issue":"13","key":"124_CR16","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1056\/NEJM199409293311301","volume":"331","author":"ME Tinetti","year":"1994","unstructured":"Tinetti ME, Baker DI, McAvay G, et al. A multifactorial intervention to reduce the risk of falling among elderly people living in the community. N Engl J Med. 1994;331(13):821\u20137.","journal-title":"N Engl J Med"},{"issue":"4","key":"124_CR17","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/europace\/eun369","volume":"11","author":"M Nabauer","year":"2009","unstructured":"Nabauer M, Gerth A, Limbourg T, et al. The registry of the german competence network on atrial fibrillation: patient characteristics and initial management. Europace. 2009;11(4):423\u201334.","journal-title":"Europace"},{"issue":"3","key":"124_CR18","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1136\/jnnp.57.3.340","volume":"57","author":"Antiarrhythmic drugs and polyneuropathy","year":"1994","unstructured":"Antiarrhythmic drugs and polyneuropathy. The collaborative group for the study of polyneuropathy. J Neurol Neurosurg Psychiatry. 1994;57(3):340\u20133.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"124_CR19","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.clinthera.2018.01.015","volume":"40","author":"C Wu","year":"2018","unstructured":"Wu C, Tcherny-Lessenot S, Dai W, et al. Assessing the risk for peripheral neuropathy in patients treated with dronedarone compared with that in other antiarrhythmics. Clin Ther. 2018;40(3):450\u20135.","journal-title":"Clin Ther"},{"key":"124_CR20","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.amjcard.2016.11.066","volume":"119","author":"WB White","year":"2017","unstructured":"White WB, Hauser RA, Rowse GJ, Ziemann A, Hewitt LA. Cardiovascular safety of droxidopa in patients with symptomatic neurogenic orthostatic hypotension. Am J Cardiol. 2017;119:1111\u20135.","journal-title":"Am J Cardiol"},{"issue":"3","key":"124_CR21","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/cpdd.393","volume":"7","author":"WB White","year":"2018","unstructured":"White WB, Hewitt LA, Mehdirad AA. Impact of the norepinephrine prodrug droxidopa on the QTc interval in healthy individuals. Clin Pharmacol Drug Dev. 2018;7(3):332\u201340.","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"11","key":"124_CR22","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.jacc.2018.05.079","volume":"72","author":"R Freeman","year":"2018","unstructured":"Freeman R, Abuzinadah AR, Gibbons C, Jones P, Miglis MG, Sinn DI. Orthostatic hypotension: JACC state-of-the-art review. J Am Coll Cardiol. 2018;72(11):1294\u2013309.","journal-title":"J Am Coll Cardiol"}],"container-title":["Cardiology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-018-0124-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40119-018-0124-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-018-0124-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T11:12:54Z","timestamp":1724411574000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40119-018-0124-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,9]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["124"],"URL":"https:\/\/doi.org\/10.1007\/s40119-018-0124-z","relation":{},"ISSN":["2193-8261","2193-6544"],"issn-type":[{"type":"print","value":"2193-8261"},{"type":"electronic","value":"2193-6544"}],"subject":[],"published":{"date-parts":[[2019,1,9]]},"assertion":[{"value":"13 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}